Navigation Links
Dan Renick, RPh, Joins The Hobart Group as Managing Partner

Strengthens firm's ability to drive clients' success in managed care

GLADSTONE, N.J., May 28 /PRNewswire/ -- The Hobart Group, a full-service managed market agency focused on securing formulary access for today's pharmaceutical brands, announces the addition of Dan Renick, RPh, as Managing Partner. Renick will provide strategic counsel to The Hobart Group's pharmaceutical and biotech clients, including GlaxoSmithKline, sanofi-aventis, and Forest Laboratories.

"Dan brings a unique managed care perspective to The Hobart Group and our clients," said Lisa B. Bair, President. "His knowledge of what matters to payers during the formulary decision process, in particular, Medicare Part D, will help address a critical need for our clients."

"There is more pressure than ever on drugmakers to maximize revenues of their key assets. In today's market, it's critical that companies are able to effectively differentiate their drugs from the competition," said Renick. "I'm excited to apply my knowledge of what payers are looking for with our clients. As the healthcare environment evolves, it is critical to provide our managed market customers with strategies that deliver innovative solutions to obtaining formulary access."

Prior to joining The Hobart Group, Renick served as Director, Corporate Pharmacy Management, at Humana Inc., a national managed care organization with more than 11 million members and the second largest Medicare Part D and Medicare Advantage sponsor. In this role, Renick was responsible for Pharmacy Programs and trade relations, including contracting oversight with both pharmaceutical companies and pharmacy provider organizations. At Merck & Co., Inc., Renick worked with large employers, business coalitions, and benefits consultants in support of rational and evidence-based benefit-design decisions.

In addition, he has worked with various other managed market segments with an emphasis on Senior Care, and spent several years in pharmacy operations at the regional and headquarters level for both retail and long-term care pharmacy providers. Renick earned his RPh degree from the University of Kentucky and his BS degree in chemistry and biology from Western Kentucky University.

About The Hobart Group

The Hobart Group is a full-service managed market agency providing specialized services aimed at obtaining formulary access. The Hobart Group has developed a full suite of technology tools to help enhance relationships with payer customers. For more information about The Hobart Group, visit

SOURCE The Hobart Group
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
3. Hank Plain Joins Morgenthaler Ventures as Partner
4. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
5. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
6. Dan Broderick Joins Prolog Ventures as Partner
7. Ingenuity Systems Joins Biomarkers Consortium
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
10. Progeniq Joins Microsoft in Bio IT Alliance
11. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... Accutest Research Laboratories, a leading ... Organization (CRO), has formed a strategic ... - Temple Health for joint work ... (Photo: ) , --> ...
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... Cepheid (NASDAQ: CPHD ) today announced ... conference, and invited investors to participate via webcast. ... December 1, 2015 at 11.00 a.m. Eastern Time ... December 1, 2015 at 11.00 a.m. Eastern Time ... York, NY      Tuesday, December 1, 2015 at ...
Breaking Biology Technology:
(Date:11/19/2015)... Nov. 19, 2015  Based on its in-depth analysis ... recognizes BIO-key with the 2015 Global Frost & Sullivan ... & Sullivan presents this award to the company that ... the needs of the market it serves. The award ... and expands on customer base demands, the overall impact ...
(Date:11/18/2015)... PHILADELPHIA , Nov. 18, 2015  As new ... in children, doctors and other healthcare providers face challenges ... counsel families and patients. In addition, as more children ... into a patient,s adulthood and old age. ... The Children,s Hospital of Philadelphia (CHOP) . ...
(Date:11/17/2015)... -- Paris from 17 th ... Paris from 17 th until 19 th ... has invented the first combined scanner in the world which ... surface. Until now two different scanners were required: one for ... on the same surface. This innovation is an ideal ...
Breaking Biology News(10 mins):